Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

Clinical trial NCT06500793 · RECRUITING

Trial details

NCT number: NCT06500793
Sponsor: Ensysce Biosciences
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Healthy Volunteer

Start date: 2024-11-24
Primary completion: 2026-12-22
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.